Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs

Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs

Background and Aim: Keratoconjunctivitis sicca (KCS) is predominantly an immune-mediated chronic inflammatory ocular disease that is commonly diagnosed in dogs. This study aimed to compare the conventional use of topical immunosuppressant tacrolimus 0.03% eye drops and a new therapy injectable homol...

Full description

Bibliographic Details
Main Authors: Giovana José Garcia Estanho, João Victor Goulart Consoni Passareli, Letícia da Silva Pando, Daniel Espinhosa Vieira, Gisele Alborghetti Nai, Cecília Laposy Santarém, Silvia Franco Andrade
Format: Article
Language:English
Published: Veterinary World 2023-01-01
Series:Veterinary World
Subjects:
dogs
homologous platelet-rich plasma
keratoconjunctivitis sicca
tacrolimus 0.03%
Online Access:http://www.veterinaryworld.org/Vol.16/January-2023/16.pdf

Similar Items

Similar Items